Brigham highlights the alarming reality of medical products and pharmaceuticals that, despite FDA approval, may not be safe for consumers. He discusses the troubling trend of pharmaceutical companies outsourcing manufacturing overseas and the lack of recent inspections, raising concerns about transparency and accountability. The discussion emphasizes the need for vigilance and critical questioning regarding the safety of medications and medical devices.
